Jobs at Vital Therapies

Leads integrated scientific communications for a biopharmaceutical pipeline, including publication planning, congress materials, field medical content, literature surveillance, and competitive intelligence. Translates Medical Affairs priorities and evidence into compliant narratives, workplans, and deliverables. Oversees external agencies and cross-functional partners, establishes scalable content processes, and ensures adherence to publication ethics, authorship standards, and medical/legal/regulatory review requirements. Supports launch readiness through scientific messaging, insights synthesis, and capability building.

Provides operational leadership for global or regional Phase 1–3 clinical studies from planning and start-up through close-out. Oversees CROs, vendors, investigative sites, study timelines, budgets, risks, enrollment, quality, compliance, documentation, and inspection readiness. Leads cross-functional teams, develops execution and monitoring plans, supports regulatory and audit activities, and mentors junior clinical operations staff.

Lead global pharmacovigilance strategy and operations, including safety systems, signal detection, benefit-risk assessment, regulatory filings, medical review, compliance, CRO oversight, and safety governance. Partner with clinical development and regulatory teams, chair executive safety committees, and build high-performing pharmacovigilance teams through hiring, mentoring, and performance management.

Own Immunic’s global brand strategy and marketing organization for a potential relapsing MS therapy launch. Lead positioning, messaging, launch planning, market research, HCP and patient marketing, digital and omnichannel strategy, budgets, agencies, and international adaptation. Build the marketing function and team from the ground up while partnering with Market Access, Medical Affairs, Regulatory, Legal, Finance, and Patient Advocacy to ensure integrated commercial launch readiness.

Build and lead Immunic’s U.S. Market Access organization for the anticipated launch of vidofludimus calcium in relapsing multiple sclerosis. Own payer strategy, pricing, contracting, reimbursement, distribution, value propositions, evidence strategy, launch readiness, and specialty pharmacy relationships. Recruit and lead field market access teams while coordinating with Commercial, Medical Affairs, Regulatory, Finance, Legal, Supply Chain, and Sales to maximize patient access and commercial success.